Valuation: Coeptis Therapeutics

Market Cap 102M 87.43M 81.8M 74.88M 141M 9.77B 142M 966M 377M 4.91B 383M 375M 16.23B P/E 2024
-1.08x
P/E 2025 -5.06x
Enterprise Value 95.98M 82.22M 76.93M 70.42M 132M 9.18B 134M 909M 354M 4.61B 360M 353M 15.26B EV / Sales 2024
-
EV / Sales 2025 51.4x
Free-Float
-
Yield 2024 *
-
Yield 2025 -
1 day-7.83%
Current month-77.74%
6 months-68.45%
Current year-74.39%
Current year 3.61
Extreme 3.61
17.27
1 year 3.61
Extreme 3.61
21.41
3 years 2.31
Extreme 2.31
27.6
5 years 2.31
Extreme 2.31
428.4
10 years 2.31
Extreme 2.31
428.4

Financials

2024 2025
Net sales - 1.36M 1.17M 1.09M 1M 1.88M 130M 1.9M 12.91M 5.03M 65.51M 5.12M 5.01M 217M
Net income -9.81M -8.41M -7.87M -7.2M -13.51M -939M -13.69M -92.93M -36.24M -472M -36.85M -36.05M -1.56B -11.92M -10.21M -9.55M -8.74M -16.41M -1.14B -16.63M -113M -44.01M -573M -44.75M -43.77M -1.89B
Net Debt 866K 742K 694K 635K 1.19M 82.87M 1.21M 8.2M 3.2M 41.63M 3.25M 3.18M 138M -6.08M -5.21M -4.87M -4.46M -8.37M -582M -8.49M -57.59M -22.46M -292M -22.84M -22.34M -967M
Logo Coeptis Therapeutics
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio is highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. It is developing a universal, multi-antigen CAR technology licensed from the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and medical researchers at the Karolinska Institute. Its NexGenAI Affiliates Network platform offers AI-powered marketing software and advanced robotic process automation capabilities. Its Coeptis Technologies division is focused on diversifying and enhancing its growth potential. Its subsidiaries include Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc. and SNAP Biosciences, Inc.
Employees
5
Sector
-
Date Price Change Volume
26-08-21 US$3.650 -7.83% 807,173
26-08-20 US$3.960 -3.65% 325,340
26-08-19 US$4.110 +6.75% 235,348
26-08-18 US$3.850 -0.26% 314,639
26-08-17 US$3.860 -2.03% 259,823
  1. Stock Market
  2. Stocks
  3. COEP Stock